Abstract
5-Lipoxygenase (5-LOX) is important enzyme in the biosynthesis of leukotrienes, and is a potential target in the treatment of asthma and allergy. We designed and synthesized a series of benzoxazoles and benzothiazoles as 5-LOX inhibitors. Fourteen compounds prepared showed the inhibition of LTC4 formation with IC(50) value of 0.12-23.88 μM. Also two compounds 2d and 2g showed improved airway hypersensitiveness.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Allergens / toxicity
-
Animals
-
Arachidonate 5-Lipoxygenase / chemistry*
-
Arachidonate 5-Lipoxygenase / metabolism
-
Asthma / chemically induced
-
Asthma / drug therapy
-
Asthma / pathology
-
Benzoxazoles / chemical synthesis
-
Benzoxazoles / chemistry*
-
Benzoxazoles / therapeutic use
-
Lipoxygenase Inhibitors / chemical synthesis*
-
Lipoxygenase Inhibitors / chemistry
-
Lipoxygenase Inhibitors / therapeutic use
-
Mice
-
Structure-Activity Relationship
Substances
-
Allergens
-
Benzoxazoles
-
Lipoxygenase Inhibitors
-
Arachidonate 5-Lipoxygenase